Over the last several years the global marketplace has created a complex matrix of supply chains, making risk profiles all the more complex. Traditionally, strict adherence to GMP by pharmaceutical supply chains was at the forefront to ensuring risks and recalls were avoided however, environmental, health and saftey (EHS) issues are now being seen as equally important when assessing supply chains risks.

Environmental sustainability has grown beyond the niche industry of ‘green’ companies and is becoming an important requirement for suppliers growth and success. Kenneth Ball, Commercial Operations Lead at Pfizer CentreOne, sat down with Specialty Chemicals to look at why environmental responsibility is now critical in the pharmaceutical supply chain.

Read the full article here.